TickerGuard
Buy Day today: Neutral (63) Broad market participation · major macro event coming up
NVAX

Novavax Inc

Healthcare · Biotechnology

10.70$ +10.0% vs. previous close Closing price · As of: Nov 4, 2026

Ownership

Ownership Structure

Who owns Novavax Inc (NVAX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.6% of the shares are freely tradable; institutional investors hold 69.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 69.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 5.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 88.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 28.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 165Mio.

Largest Shareholders

Institutions

Institutions NVAX
Name Stake (%) Shares Change (%) Date
BlackRock Inc 8.46 13,946,881 +8.6 06/30/2026
Shah Capital Management 7.38 12,173,481 -14.1 09/30/2026
State Street Corp 7.12 11,740,550 +30.9 06/30/2026
Vanguard Portfolio Management, LLC 4.61 7,607,996 +6.4 06/30/2026
Vanguard Capital Management, LLC 4.40 7,257,449 +1.8 06/30/2026
Sanofi 4.17 6,880,481 +0.0 06/30/2026
D. E. Shaw & Co LP 3.43 5,650,905 -26.7 06/30/2026
Geode Capital Management, LLC 2.55 4,207,370 +7.9 06/30/2026

Funds

Funds NVAX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.15 5,197,170 +0.0 09/30/2026
State Street® SPDR® S&P® Biotech ETF 2.81 4,633,735 -1.9 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?